Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -15.73 % |
3 Month Return | -35.56 % |
1 Year Return | -5.82 % |
Market Stats | |
Previous Close | ₹16.02 |
Open | ₹16.25 |
Volume | 4.87L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹364.37Cr |
P/E Ratio | 22.25 |
PEG Ratio | 158.93 |
Market Cap | ₹364.37 Cr |
P/B Ratio | 2.18 |
EPS | 0.58 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 9.45 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹364.37 Cr | 103.71% | 0.51 | ₹13 Cr | ₹86 Cr | |
NA | ₹5,032.96 Cr | 69.81% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
NA | ₹136.04 Cr | 39.92% | 0.57 | NA | NA | |
NA | ₹1,704.92 Cr | -2.91% | 0.62 | ₹57 Cr | ₹398 Cr | |
NA | ₹862.49 Cr | 210.58% | 0.62 | ₹28 Cr | ₹125 Cr |
Organisation | Gennex Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 30.79 Cr → 33.38 Cr (in ₹), with an average increase of 7.8% per quarter
Profit Spike
Netprofit is up for the last 4 quarters, 2.76 Cr → 5.37 Cr (in ₹), with an average increase of 18.4% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 49.7% return, outperforming this stock by 55.5%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 129.1% return, outperforming this stock by 21.3%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.58% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.42% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Gennex Lab. stock has moved down by -8.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.42% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.58% | 0.00 | |
Others | 0% | 0.00 |
Gennex Laboratories Ltd in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (22.25x)
December 24, 2024
Industry (56.56x)
December 24, 2024
Highest (86.13x)
August 3, 2018
Gennex Laboratories Ltd’s net profit jumped 74.92% since last year same period to ₹5.37Cr in the Q2 2024-2025. On a quarterly growth basis, Gennex Laboratories Ltd has generated 15.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Gennex Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Gennex Laboratories Ltd (531739) share price today is ₹15.8
Gennex Laboratories Ltd is not listed on NSE
Gennex Laboratories Ltd is listed on BSE
PE Ratio of Gennex Laboratories Ltd is 22.25
PE ratio = Gennex Laboratories Ltd Market price per share / Gennex Laboratories Ltd Earnings per share
Today’s traded volume of Gennex Laboratories Ltd(531739) is 4.87L.
Today’s market capitalisation of Gennex Laboratories Ltd(531739) is ₹364.37Cr.
Gennex Laboratories Ltd(531739 | Price |
---|---|
52 Week High | ₹29 |
52 Week Low | ₹13.25 |
Gennex Laboratories Ltd(531739) share price is ₹15.8. It is down -45.52% from its 52 Week High price of ₹29
Gennex Laboratories Ltd(531739) share price is ₹15.8. It is up 19.25% from its 52 Week Low price of ₹13.25
Gennex Laboratories Ltd(531739 | Returns |
---|---|
1 Day Returns | -0.22% |
1 Month Returns | -15.73% |
3 Month Returns | -35.56% |
1 Year Returns | -5.82% |